| Attributes | Values |
|---|
| rdf:type
| |
| description
| - videnskabelig artikel (da)
- article científic (ca)
- articolo scientifico (it)
- artigo científico (pt)
- bilimsel makale (tr)
- vedecký článok (sk)
- vetenskaplig artikel (sv)
- vědecký článek (cs)
- wetenschappelijk artikel (nl)
- wissenschaftlicher Artikel (de)
- научни чланак (sr)
- article scientifique (fr)
- наукова стаття, опублікована в липні 1998 (uk)
- مقالة علمية نشرت في يوليو 1998 (ar)
- scientific article published on July 1998 (en)
- artículu científicu espublizáu en xunetu de 1998 (ast)
|
| publication date
| |
| publication date
| |
| language of work or name
| |
| language of work or name
| |
| author name string
| |
| author name string
| - D Henry
- G Bensch
- L Harper
- S Chodosh
- A Jubran
- G H Talbot
- C A DeAbate
- D Tipping
|
| rdfs:label
| - Sparfloxacin vs ofloxacin in the treatment of acute bacterial exacerbations of chronic bronchitis: a multicenter, double-blind, randomized, comparative study. Sparfloxacin Multicenter ABECB Study Group (en)
- Sparfloxacin vs ofloxacin in the treatment of acute bacterial exacerbations of chronic bronchitis: a multicenter, double-blind, randomized, comparative study. Sparfloxacin Multicenter ABECB Study Group (nl)
|
| skos:prefLabel
| - Sparfloxacin vs ofloxacin in the treatment of acute bacterial exacerbations of chronic bronchitis: a multicenter, double-blind, randomized, comparative study. Sparfloxacin Multicenter ABECB Study Group (en)
- Sparfloxacin vs ofloxacin in the treatment of acute bacterial exacerbations of chronic bronchitis: a multicenter, double-blind, randomized, comparative study. Sparfloxacin Multicenter ABECB Study Group (nl)
|
| name
| - Sparfloxacin vs ofloxacin in the treatment of acute bacterial exacerbations of chronic bronchitis: a multicenter, double-blind, randomized, comparative study. Sparfloxacin Multicenter ABECB Study Group (en)
- Sparfloxacin vs ofloxacin in the treatment of acute bacterial exacerbations of chronic bronchitis: a multicenter, double-blind, randomized, comparative study. Sparfloxacin Multicenter ABECB Study Group (nl)
|
| title
| |
| title
| - Sparfloxacin vs ofloxacin in the treatment of acute bacterial exacerbations of chronic bronchitis: a multicenter, double-blind, randomized, comparative study. Sparfloxacin Multicenter ABECB Study Group (en)
|
| page(s)
| |
| page(s)
| |
| instance of
| |
| instance of
| |
| main subject
| |
| main subject
| |
| PubMed ID
| |
| PubMed ID
| |
| PubMed ID
| |
| published in
| |
| published in
| |
| issue
| |
| volume
| |
| issue
| |
| volume
| |
| DOI
| |
| DOI
| |
| DOI
| |
| is about
of | |
| is cites work
of | - Pseudomonal infections in patients with COPD: epidemiology and management
- Randomised double-blind comparison of oral gatifloxacin and co-amoxiclav for acute exacerbation of chronic Bronchitis
- Chlamydia pneumoniae, asthma, and COPD: what is the evidence?
- Microbiologic efficacy of moxifloxacin for the treatment of community-acquired pneumonia due to Chlamydia pneumoniae
- Safety profile of sparfloxacin, a new fluoroquinolone antibiotic
- Selection of clinical, patient-reported, and economic end points in acute exacerbation of chronic bronchitis
- Treating acute bacterial exacerbations of chronic bronchitis in patients unresponsive to previous therapy: Sparfloxacin versus clarithromycin
- Bacterial infection in chronic obstructive pulmonary disease in 2000: a state-of-the-art review
- Role of infection and antimicrobial therapy in acute exacerbations of chronic obstructive pulmonary disease
- The new antibiotics
- Potential interactions of the extended-spectrum fluoroquinolones with the CNS.
- Sparfloxacin versus ciprofloxacin for the treatment of community-acquired, complicated skin and skin-structure infections.
- Fluoroquinolone adverse effects and drug interactions
- Fluoroquinolones for the treatment of outpatient community-acquired pneumonia
- Activity of grepafloxacin and other fluoroquinones and newer macrolides against recent clinical isolates of Chlamydia pneumoniae
- Do we need new antibiotics for treating exacerbations of COPD?
- Sparfloxacin: a review
- Second consensus report on the use of antimicrobial agents in exacerbations of chronic obstructive pulmonary disease
- Uso de antimicrobianos en la exacerbación de la enfermedad pulmonar obstructiva crónica
- Acute exacerbations of chronic bronchitis: what role for the new fluoroquinolones?
- Activity of quinolones against Chlamydia pneumoniae
- Comparison of the in vitro activity of and pathogen responses to sparfloxacin with those of other agents in the treatment of respiratory tract, urinary tract, and skin and skin-structure infections
- Electrophysiologic, pharmacokinetic, and pharmacodynamic values indicating a higher risk of torsades de pointes
- [Treatment failure of acute exacerbations of chronic obstructive airways disease risk factors and clinical relevance]
- Uso de antimicrobianos en la exacerbación de la enfermedad pulmonar obstructiva crónica
- Effects of food on the pharmacokinetics of sparfloxacin
- Health status and costs of exacerbations of chronic bronchitis and COPD: how to improve antibiotic treatment.
|
| is cites work
of | |
![[RDF Data]](/fct/images/sw-rdf-blue.png)
![[cxml]](/fct/images/cxml_doc.png)
![[csv]](/fct/images/csv_doc.png)
![[text]](/fct/images/ntriples_doc.png)
![[turtle]](/fct/images/n3turtle_doc.png)
![[ld+json]](/fct/images/jsonld_doc.png)
![[rdf+json]](/fct/images/json_doc.png)
![[rdf+xml]](/fct/images/xml_doc.png)
![[atom+xml]](/fct/images/atom_doc.png)
![[html]](/fct/images/html_doc.png)